Literature DB >> 23986357

Ligand/PTC-free intramolecular Heck reaction: synthesis of pyrroloquinoxalines and their evaluation against PDE4/luciferase/oral cancer cell growth in vitro and zebrafish in vivo.

P Vijaya Babu1, Soumita Mukherjee, Girdhar Singh Deora, Keerthana Sarma Chennubhotla, Raghavender Medisetti, Swapna Yellanki, Pushkar Kulkarni, Shivashankar Sripelly, Kishore V L Parsa, Kiranam Chatti, K Mukkanti, Manojit Pal.   

Abstract

A series of 1,3-disubstituted pyrrolo[2,3-b]quinoxalines has been designed for the potential inhibition of PDE4 without inhibiting luciferase. A ligand/PTC (phase transfer catalyst) free intramolecular Heck cyclization strategy was used to prepare these compounds, some of which showed significant inhibition of PDE4B (IC50≈ 5-14 μM) and growth inhibition of oral cancer cells (CAL 27) but not inhibition of luciferase in vitro. They also showed acceptable safety profiles but no apoptosis in zebrafish embryos.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986357     DOI: 10.1039/c3ob41504j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  One-pot synthesis of biologically active 1,2,3-trisubstituted pyrrolo[2,3-b]quinoxalines through a palladium-catalyzed reaction with internal alkyne moieties.

Authors:  Ali Keivanloo; Tayebeh Besharati-Seidani; Babak Kaboudin; Akihiro Yoshida; Tsutomu Yokomatsu
Journal:  Mol Divers       Date:  2018-06-16       Impact factor: 2.943

Review 2.  PDE4 subtypes in cancer.

Authors:  Samuel Hsien Lai; Guston Zervoudakis; Jesse Chou; Mark E Gurney; Kelly M Quesnelle
Journal:  Oncogene       Date:  2020-03-20       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.